The Attitudes and Practices of Nursing Students on Intimate Partner Violence

The Effect of Screen-based Simulation Method on the Attitudes and Practices of Nursing Students on Intimate Partner Violence

The purpose of this research is to determine the effect of screen-based simulation method on nursing students' attitudes and practices about intimate partner violence against women.

Study Overview

• Status: Completed
• Conditions: Nursing Students
• Intervention / Treatment: Other: Screen-based simulation

Detailed Description

Intimate partner violence (ipv) against women is characterized as a global epidemic in health care delivery due to its prevalence, high morbidity, and mortality. One of the first healthcare providers that victims interact with is nurses. Nurses should have sufficient knowledge and skills to fulfill their roles and responsibilities defined in the issue of ipv against women. Educational environments must provide nursing students with the opportunity to be aware of ipv against women and to manage cases. Institutions that add simulation content to their education programs have the potential to become the gold standard when preparing nursing students for case management of ipv against women. Screen-based simulations (SBSs) use available digital technology to represent patients, populations, or other healthcare encounters on a computer screen or a mobile tablet, smartphone, or other screen-based devices. Simulations using screens have advantages over mannequin-based simulations-the software is infinitely replicable, the simulation programs can be portable, they can be accessed asynchronously without a live instructor present, and the software can be distributed to many devices, and the programming can track massive amounts of usage data. The purpose of this research is to determine the effect of screen-based simulation method on nursing students' attitudes and practices about intimate partner violence against women. The intervention and control groups of the study with the pre-test, post-test randomized controlled experimental design will comprise fourth-year students attending a university's nursing faculty. Power analysis was performed to calculate the sample size and it was planned to include 63 students in the sample group. In the research, the intervention group will be trained on ipv through SBSs whereas the control group will be trained via online conference. The research outputs will be measured by Health Workers' Attitudes and Practices on Intimate Partner Violence Against Women Scale, Simulation Design Scale and Debriefing Experience Scale.

• Study Type: Interventional
• Enrollment (Actual): 53
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • İzmir, Turkey, 35560
    • Ege University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Volunteering to participate in the study
• Being a 4th-year student in the nursing department

Exclusion Criteria:

• Having worked as a nurse before
• To have taken an elective course on violence against women in undergraduate education
• To be married

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Screen-based simulation; Screen-based simulation about intimate partner violence against women prepared by researchers will apply to nursing students.	Other: Screen-based simulation; In the research, training will be given to the experiment group on intimate partner violence against women through screen-based simulation.
No Intervention: Control group; Online didactic education about intimate partner violence against women prepared by researchers will apply to nursing students.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Attitudes and Practices of Healthcare Providers Regarding Intimate Partner Violence (APHCPs-IPV) survey scale	The Turkish version of the scale of 42 items and consists of eight subscales. The subscales are (a) preparedness, (b) self-confidence of the practitioner, (c) lack of control, (d) comfort following disclosure, (e) professional support, (f) practice pressures, (g) abuse inquiries, and (h) practitioner consequences of asking. It is scored on a 4-point scale ranging from 1 to 4 (1- strongly agree, 2 agree, 3-disagree, and 4-strongly disagree). The APHCPs-IPV scale total scores range from 42 to 168. Higher scores reflected greater self-reported preparedness, self-confidence, feelings of professional support, comfort with abuse inquiries, and comfort with discussions following disclosure as well as decreased concern about the consequences of abuse inquiries and decreased feelings of no control and system pressures.	Before the recruit pre-test (APHCPs-IPV survey scale) will be applied. Six months after the intervention post-test (APHCPs-IPV survey scale) again will be applied. Researchers will measure change from APHCPs-IPV survey scale at 6 months.

Collaborators and Investigators

• Sponsor: Ege University

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2023
• Primary Completion (Actual): June 30, 2023
• Study Completion (Actual): July 30, 2023

Study Registration Dates

• First Submitted: July 18, 2022
• First Submitted That Met QC Criteria: July 28, 2022
• First Posted (Actual): August 1, 2022

Study Record Updates

• Last Update Posted (Actual): August 1, 2023
• Last Update Submitted That Met QC Criteria: July 30, 2023
• Last Verified: July 1, 2023

More Information

Terms related to this study

• Keywords: intimate partner violence; nursing student; screen-based simulation
• Other Study ID Numbers: 714

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No